As of December 2024, Arbutus Biopharma has a market cap of $596.99M. This makes Arbutus Biopharma the world's 10840th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $486.32M | 16.00% |
2023 | $419.24M | 7.30% |
2022 | $390.73M | -40.10% |
2021 | $652.33M | 9.58% |
2020 | $595.32M | 27.70% |
2019 | $466.19M | -27.42% |
2018 | $642.27M | -24.16% |
2017 | $846.86M | 106.12% |
2016 | $410.85M | -44.94% |
2015 | $746.24M | -70.63% |
2014 | $2.54B | 90.09% |
2013 | $1.34B | 60.69% |
2012 | $831.77M | 230.67% |
2011 | $251.54M | -68.09% |
2010 | $788.17M | 2.17% |
2009 | $771.40M | 217.24% |
2008 | $243.16M | -68.13% |
2007 | $763.01M | - |